References
- Access Economics. (2004). Delaying the Onset of Alzheimer's Disease: Projections and Issues. Canberra: Alzheimer's Australia.
- Access Economics. (2009). Keeping Dementia Front of Mind: Incidence and Prevalence 2009–2050. Canberra: Alzheimer's Australia.
- AD International. (2010). World Alzheimer Report 2010: The Global Economic Impact of Dementia. London: Alzheimer's Disease International.
- AD International. (2009). World Alzheimer Report (2009). London: Alzheimer's Disease International.
- AIHW. (2012). Dementia in Australia. Canberra: Australian Institute of Health and Welfare.
- Appannah, A., Szoeke, C., Ellis, K., Rowe, C., Martins, R., Masters, C., … Bush, A. (2012a). The Commonwealth Scientific and Industrial Research Organisation report: Vascular risk and cognition – A combined cohort study.
- Appannah, A., Szoeke, C., Ellis, K., Rowe, C., Martins, R., Masters, C., … The AIBL Research Group. (2012b). Investigating cardiovascular risk factors on cognition: A two-cohort study. Alzheimer's and Dementia, 8(4), S318–319.
- Australian Bureau of Statistics. (1999). Disability, Ageing, and Carers: Summary of Findings, 1998. Retrieved from http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf-/0/CA25687100069892CA25688800206521/$File/44300_1998.pdf
- Australian Bureau of Statistics. (2011). Australian Social Trends cat. no. 4102.0. Retrieved from http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/LookupAttach/4102.0Publication23.03.112/$File/41020_Lifeexpectancy_Mar2011.pdf
- Australian Government Department of Health and Ageing. (2013). Strategic Review of Health and Medical Research. Canberra: Australian Government Department of Health and Ageing.
- Barry, L.C., Abou, J.J., Simen, A.A. & Gill, T.M. (2012). Under-treatment of depression in older persons. Journal of Affective Disorders, 136, 789–796.
- Benke, T., Delazer, M., Sanin, G., Schmidt, H., Seiler, S., Ransmayr, G., … Schmidt, R. (2013). Cognition, gender, and functional abilities in Alzheimer's disease: How are they related? Journal of Alzheimer's Disease, 35, 247–252.
- Bromberger, J.T., Kravitz, H.M., Chang, Y.F., Cyranowski, J.M., Brown, C. & Matthews, K.A. (2011). Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychological Medicine, 41, 1879–1888.
- Campbell, K., Szoeke, C., Dennerstein, L. & Ames, D. (2012). Depression in the postmenopausal years: The second decade of follow-up in the Women's Healthy Ageing Project. Paper presented at the 16th Australasian Menopause Society Congress, Melbourne, Australia. Feb 12-Sun 14 October 2012.
- Carrillo, M.C., Bain, L.J., Frisoni, G.B. & Weiner, M.W. (2012). Worldwide Alzheimer's disease neuroimaging initiative. Alzheimer's and Dementia, 8, 337–342.
- Chen, K., Lowndes, G., Ames, D. & Szoeke, C. (2012). Variability in mid-life high-denisty lipoprotein cholesterol (HDL-C) is related to poorer late-life episodic memory: The Women's Healthy Ageing Project (WHAP). Alzheimer's and Dementia, 8(4), S499.
- Chételat, G., Villemagne, V.L., Bourgeat, P., Pike, K.E., Jones, G., Ames, D., … Australian Imaging Biomarkers and Lifestyle Research Group. (2010). Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Annals of Neurology, 67, 317–324.
- DeCarli, C. (2013). Clinically asymptomatic vascular brain injury: A potent cause of cognitive impairment among older individuals. Journal of Alzheimer's Disease, 33, S417–S426.
- Delis, D.C., Kaplan, E. & Kramer, J.H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio, TZ: Psychological Corporation.
- Delis, D.C., Kramer, J.H., Kaplan, E. & Ober, B.A. (2000). California Verbal Learning Test - Second Edition. San Antonio, TX: Psychological Corporation.
- Dennerstein, L., Dudley, E.C., Hopper, J.L., Guthrie, J.R. & Burger, H.G. (2000). A prospective population-based study of menopausal symptoms. Obstetrics and Gynecology, 96, 351–358.
- Dennerstein, L., Smith, A.M.A. & Morse, C. (1994). Psychological well-being, mid-life, and the menopause. Maturitas, 20, 1–11.
- Desmond, P., Cummins, T., Ames, D., Dennerstein, L. & Szoeke, C. (2013). The relationship between hassle severity, anxiety and cognitive performance: An 8 year follow-up in the Women's Health Ageing Project. Alzheimer's and Dementia, 9, 457.
- Ellis, K., Szoeke, C., Bush, A., Darby, D., Graham, P.L., Lautenschlager, N.T., … AIBL Research Group. (doi: 10.1017/s1041610213001956). Rates of diagnostic transition and cognitive change at 18 month follow up among 1112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). International Psychogeriatrics.
- Ellis, K.A., Bush, A.I., Darby, D., De Fazio, D., Foster, J., Hudson, P., … AIBL Research Group. (2009). The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672–687.
- Gandy, S. & DeKosky, S.T. (2013). Toward the treatment and prevention of Alzheimer's disease: Rational strategies and recent progress. Annual Review of Medicine, 64, 367–383.
- Gfeller, J.D. & Horn, G.J. (1996). The East Boston Memory Test: A clinical screening measure for memory impairment in the elderly. Journal of Clinical Psychology, 52(2), 191–196.
- Greendale, G.A., Huang, M.-H., Leung, K., Crawford, S.L., Gold, E.B., Wight, R., … Karlamangla, A.S. (2012). Dietary phytoestrogen intakes and cognitive function during the menopausal transition: results from the Study of Women's Health Across the Nation Phytoestrogen Study. Menopause, 19, 894–903.
- Greendale, G.A., Huang, M.-H., Wight, R.G., Seeman, T., Luetters, C., Avis, N.E., … Karlamangla, A.S. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 72, 1850–1857.
- Henderson, V.W., Guthrie, J.R., Dudley, E.C., Burger, H. G. & Dennerstein, L. (2003). Estrogen exposures and memory at midlife. Neurology, 60, 1369–1371.
- Jack, C.R., Jr, Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., … Trojanowski, J.Q. (2010). Personal View: Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. The Lancet Neurology, 9, 119–128.
- Jagust, W. J., Bandy, D., Chen, K., Foster, N. L., Landau, S. M., Mathis, C. A., … the Alzheimer's Disease Neuroimaging Initiative. (2010). The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's and Dementia, 6, 221–229.
- Judd, F., Hickey, M. & Bryant, C. (2012). Depression and midlife: Are we overpathologising the menopause? Journal of Affective Disorders, 136, 199–211.
- Lissner, L., Skoog, I., Andersson, K., Beckman, N., Sundh, V., Waern, M., … Björkelund, C. (2003). Participation bias in longitudinal studies: Experience from the Population Study of Women in Gothenburg, Sweden. Scandinavian Journal of Primary Health Care, 21, 242–247.
- Maki, P.M., Dennerstein, L., Clark, M., Guthrie, J., LaMontagne, P., Fornelli, D., … Resnick, S.M. (2011). Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Research, 1379, 232–243.
- Maki, P.M. & Sundermann, E. (2009). Hormone therapy and cognitive function. Human Reproduction Update, 15, 667–681.
- Meyers, J.E. & Meters, K.R. (1995). Rey Complex Figure Test and Recognition Trial. Professional Manual: Psychological Assessment Resource, Inc.
- Mohs, R.C., Knopman, D., Petersen, R.C., Ferris, S.H., Ernesto, C., Grundman, M., . . . Thal, L.J. (1997). Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope. The Alzheimer’s Disease Cooperative Study. Alzheimer Disease and Associated Disorders, 11, S13–S21.
- Morris, J.C., Roe, C.M., Xiong, C., Fagan, A.M., Goate, A.M., Holtzman, D.M. & Mintun, M.A. (2010). APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Annals of Neurology, 67(1), 122–131.
- Mullard, A. (2012). Sting of Alzheimer's failures offset by upcoming prevention trials. Nature Reviews Drug Discovery, 11, 657–660.
- National Institutes of Health. (2010). NIH state-of-the-science conference statement on preventing Alzheimer's disease and cognitive decline. NIH Consensus and State-of-the-Science Statements, 27(4), 1–27.
- Nelson, H.E. & Willison, J.R. (1991). National Adult Reading Test (NART): Test manual (2nd ed.). Windsor: NFER-Nelson.
- Pike, K., Ellis, K.A., Villemagne, V.L., Good, N., Chételat, G., Ames, D., … Rowe, C.C. (2011). Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study. Neuropsychologia, 49, 2384–2390.
- Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W. & Ferri, C.P. (2013). The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer's and Dementia, 9, 63–75.
- Reed, B.R., Marchant, N.L., Jagust, W.J., DeCarli, C.C., Mack, W. & Chui, H.C. (2012). Coronary risk correlates with cerebral amyloid deposition. Neurobiology of Aging, 33, 1979–1987.
- Rinne, J.O., Brooks, D.J., Rosser, M.N., Fox, N.C., Bullock, R., Klunk, W.E., … Grundman, M. (2010). 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: A phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurology, 9, 363–372.
- Rowe, C., Ackermann, U., Browne, W., Mulligan, R.S., Pike, K., O’Keefe, G., … Villemagne, V. (2008). Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurology, 7, 129–135.
- Rowe, C.C., Ellis, K.A., Rimajova, M., Bourgeat, P., Pike, K.E., Jones, G., … Villemagne, V. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging, 31, 1275–1283.
- Ryan, J., Stanczyk, F.Z., Dennerstein, L., Mack, W., Clark, M.S., Szoeke, C., … Henderson, V.W. (2012). Hormone levels and cognitive function in postmenopausal midlife women. Neurobiology of Aging, 33, 1138–1147.
- Salloway, S., Sperling, R., Gilman, S., Fox, N.C., Blennow, K., Raskind, M., … Bapineuzumab 201 Clinical Trial Investigators. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology, 73, 2061–2070.
- Saxton, J., Ratcliff, G., Munro, C.A., Coffey, C.E., Becker, J.T., Fried, L. & Kuller, L. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. The Clinical Neuropsychologist, 14(4), 526–534.
- Shepardson, N.E., Shankar, G.M. & Selkoe, D.J. (2011). Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Archives of Neurology, 68, 1385–1392.
- Smith, A.M.A. (1982). Symbol Digits Modalities Test. Los Angeles: Western Psychological Services.
- Strauss, E., Sherman, E.M.S. & Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd ed.). New York: Oxford University Press.
- Szoeke, C., Henderson, V.W., Ames, D. & Dennerstein, L. (2011). Reported memory complaints. Alzheimer's and Dementia, 7(4), S365.
- Vickland, V., Werner, J., Morris, T., McDonnell, G., Draper, B., Low, L.-F. & Brodaty, H. (2011). Who pays and who benefits? How different models of shared responsibilities between formal and informal carers influence projections of costs of dementia management. BMC Public Health, 11, 793.
- Villemagne, V.L., Burnham, S., Bourgeot, P., Brown, B., Ellis, K.A., Salvado, O., … Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. (2013). Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurology, 12, 357–367.
- Wechsler, D. (1997a). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio, TX: Psychological Corporation.
- Wechsler, D. (1997b). Wechsler Memory Scale (3rd ed.). San Antonio, TX: Psychological Corporation.
- Wechsler, D. (2001). Wechsler Test of Adult Reading: Examiner’s Manual. San Antonio, TX: Psychological Corporation.
- Welsh, K., Butters, N., Mohs, R., Beekly, D., Edland, S., Fillenbaum, G. & Heyman, A. (1994). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part V: A normative study of the neuropsychological battery. Neurology, 44, 609–614.
- WHO. (2011). Global Health and Ageing. NIH Publication no. 11-7737. Bethesda, MD: National Institute on Aging, National Institutes of Health and World Health Organization.
- Wimo, A., Jönsson, L., Bond, J., Prince, M., Winblad, B. & Alzheimer Disease International. (2010). The worldwide economic impact of dementia. Alzheimer's and Dementia, 9, 1–11.
- Wolf, P.A. (2012). Contributions of the Framingham Heart Study to stroke and dementa epidemiologic research at 60 years. Archives of Neurology, 69, 567–571.
- Wortmann, M. (2011). Global economic cost of dementia. Alzheimer's and Dementia, 7(4), S633.
- Yang, L., Rieves, D. & Ganley, C. (2012). Brain amyloid imaging – FDA approval of Florbetapir F18. New England Journal of Medicine, 367, 885–887.
- Yates, P., Szoeke, C., Rowe, C., Villemagne, V., Steward, C., Masters, C., … Desmond, P. (2013). Ten-year MRI changes and FBB-PET: Results from the Women's Healthy Aging Project (WHAP). Alzheimer's and Dementia, 9(4), S401.